nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP2D6—breast cancer	0.133	0.583	CbGaD
Fluphenazine—ABCB1—breast cancer	0.0948	0.417	CbGaD
Fluphenazine—HTR6—Raloxifene—breast cancer	0.0791	0.215	CbGbCtD
Fluphenazine—Promazine—Tamoxifen—breast cancer	0.0701	1	CrCrCtD
Fluphenazine—CYP1A2—Anastrozole—breast cancer	0.0331	0.0899	CbGbCtD
Fluphenazine—CYP1A2—Toremifene—breast cancer	0.0303	0.0822	CbGbCtD
Fluphenazine—ABCB1—Toremifene—breast cancer	0.0265	0.0719	CbGbCtD
Fluphenazine—CYP2D6—Idarubicin—breast cancer	0.0207	0.0561	CbGbCtD
Fluphenazine—ABCB1—Lapatinib—breast cancer	0.0193	0.0524	CbGbCtD
Fluphenazine—CYP2E1—Tamoxifen—breast cancer	0.0191	0.0519	CbGbCtD
Fluphenazine—CYP2E1—Mitoxantrone—breast cancer	0.0186	0.0506	CbGbCtD
Fluphenazine—CYP1A2—Tamoxifen—breast cancer	0.0111	0.03	CbGbCtD
Fluphenazine—ABCB1—Vinorelbine—breast cancer	0.0107	0.0291	CbGbCtD
Fluphenazine—CYP2D6—Vinorelbine—breast cancer	0.0101	0.0274	CbGbCtD
Fluphenazine—ABCB1—Tamoxifen—breast cancer	0.00966	0.0263	CbGbCtD
Fluphenazine—ABCB1—Mitoxantrone—breast cancer	0.00943	0.0256	CbGbCtD
Fluphenazine—CYP2D6—Tamoxifen—breast cancer	0.00911	0.0247	CbGbCtD
Fluphenazine—ABCB1—Gemcitabine—breast cancer	0.00833	0.0226	CbGbCtD
Fluphenazine—CYP1A2—Fluorouracil—breast cancer	0.00814	0.0221	CbGbCtD
Fluphenazine—ABCB1—Paclitaxel—breast cancer	0.00752	0.0204	CbGbCtD
Fluphenazine—ABCB1—Irinotecan—breast cancer	0.00742	0.0202	CbGbCtD
Fluphenazine—ABCB1—Vinblastine—breast cancer	0.0066	0.0179	CbGbCtD
Fluphenazine—CYP2D6—Vinblastine—breast cancer	0.00622	0.0169	CbGbCtD
Fluphenazine—ABCB1—Docetaxel—breast cancer	0.00544	0.0148	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—breast cancer	0.00405	0.011	CbGbCtD
Fluphenazine—ABCB1—Methotrexate—breast cancer	0.00393	0.0107	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—breast cancer	0.00382	0.0104	CbGbCtD
Fluphenazine—CALM3—mammary gland—breast cancer	0.0012	0.0363	CbGeAlD
Fluphenazine—CALM3—nipple—breast cancer	0.000994	0.03	CbGeAlD
Fluphenazine—CALM1—mammary gland—breast cancer	0.00094	0.0284	CbGeAlD
Fluphenazine—Trifluoperazine—S100A4—breast cancer	0.000806	0.253	CrCbGaD
Fluphenazine—CALM2—nipple—breast cancer	0.000781	0.0236	CbGeAlD
Fluphenazine—CALM1—nipple—breast cancer	0.000777	0.0235	CbGeAlD
Fluphenazine—CALM2—embryo—breast cancer	0.000644	0.0194	CbGeAlD
Fluphenazine—CALM1—embryo—breast cancer	0.000641	0.0194	CbGeAlD
Fluphenazine—CYP1A2—nipple—breast cancer	0.000606	0.0183	CbGeAlD
Fluphenazine—CALM3—endometrium—breast cancer	0.0006	0.0181	CbGeAlD
Fluphenazine—HRH1—nipple—breast cancer	0.000567	0.0171	CbGeAlD
Fluphenazine—ADRA2A—nipple—breast cancer	0.000557	0.0168	CbGeAlD
Fluphenazine—CALM3—uterus—breast cancer	0.000553	0.0167	CbGeAlD
Fluphenazine—CALM3—pituitary gland—breast cancer	0.000543	0.0164	CbGeAlD
Fluphenazine—CALM3—adipose tissue—breast cancer	0.000541	0.0163	CbGeAlD
Fluphenazine—CALM2—epithelium—breast cancer	0.000526	0.0159	CbGeAlD
Fluphenazine—CALM1—epithelium—breast cancer	0.000523	0.0158	CbGeAlD
Fluphenazine—CALM2—skin of body—breast cancer	0.0005	0.0151	CbGeAlD
Fluphenazine—CALM1—skin of body—breast cancer	0.000498	0.015	CbGeAlD
Fluphenazine—CALM3—adrenal gland—breast cancer	0.000485	0.0146	CbGeAlD
Fluphenazine—HTR2C—female reproductive system—breast cancer	0.000472	0.0142	CbGeAlD
Fluphenazine—CALM2—endometrium—breast cancer	0.000471	0.0142	CbGeAlD
Fluphenazine—CALM3—bone marrow—breast cancer	0.00047	0.0142	CbGeAlD
Fluphenazine—CALM1—endometrium—breast cancer	0.000469	0.0142	CbGeAlD
Fluphenazine—CALM3—female gonad—breast cancer	0.000453	0.0137	CbGeAlD
Fluphenazine—CALM2—uterus—breast cancer	0.000434	0.0131	CbGeAlD
Fluphenazine—CALM1—uterus—breast cancer	0.000432	0.013	CbGeAlD
Fluphenazine—CALM2—pituitary gland—breast cancer	0.000427	0.0129	CbGeAlD
Fluphenazine—CALM2—adipose tissue—breast cancer	0.000425	0.0128	CbGeAlD
Fluphenazine—CALM1—pituitary gland—breast cancer	0.000425	0.0128	CbGeAlD
Fluphenazine—CALM1—adipose tissue—breast cancer	0.000423	0.0128	CbGeAlD
Fluphenazine—DRD2—pituitary gland—breast cancer	0.000392	0.0118	CbGeAlD
Fluphenazine—HTR2A—embryo—breast cancer	0.000391	0.0118	CbGeAlD
Fluphenazine—CALM2—female reproductive system—breast cancer	0.000391	0.0118	CbGeAlD
Fluphenazine—CALM1—female reproductive system—breast cancer	0.000389	0.0117	CbGeAlD
Fluphenazine—HTR1A—adrenal gland—breast cancer	0.000388	0.0117	CbGeAlD
Fluphenazine—HRH1—epithelium—breast cancer	0.000382	0.0115	CbGeAlD
Fluphenazine—CALM2—adrenal gland—breast cancer	0.000381	0.0115	CbGeAlD
Fluphenazine—CALM1—adrenal gland—breast cancer	0.000379	0.0114	CbGeAlD
Fluphenazine—CALM2—bone marrow—breast cancer	0.000369	0.0111	CbGeAlD
Fluphenazine—CALM1—bone marrow—breast cancer	0.000367	0.0111	CbGeAlD
Fluphenazine—CALM2—female gonad—breast cancer	0.000355	0.0107	CbGeAlD
Fluphenazine—CALM1—female gonad—breast cancer	0.000354	0.0107	CbGeAlD
Fluphenazine—HRH1—endometrium—breast cancer	0.000342	0.0103	CbGeAlD
Fluphenazine—HTR1A—endocrine gland—breast cancer	0.000336	0.0101	CbGeAlD
Fluphenazine—ADRA2A—endometrium—breast cancer	0.000336	0.0101	CbGeAlD
Fluphenazine—CALM2—endocrine gland—breast cancer	0.000331	0.00997	CbGeAlD
Fluphenazine—CALM1—endocrine gland—breast cancer	0.000329	0.00993	CbGeAlD
Fluphenazine—HTR2A—epithelium—breast cancer	0.000319	0.00962	CbGeAlD
Fluphenazine—ADRA2A—uterus—breast cancer	0.00031	0.00935	CbGeAlD
Fluphenazine—HRH1—adipose tissue—breast cancer	0.000309	0.00931	CbGeAlD
Fluphenazine—ADRA2A—pituitary gland—breast cancer	0.000304	0.00918	CbGeAlD
Fluphenazine—DRD2—endocrine gland—breast cancer	0.000304	0.00917	CbGeAlD
Fluphenazine—ADRA2A—adipose tissue—breast cancer	0.000303	0.00914	CbGeAlD
Fluphenazine—CALM3—lymph node—breast cancer	0.000291	0.00878	CbGeAlD
Fluphenazine—HRH1—female reproductive system—breast cancer	0.000284	0.00856	CbGeAlD
Fluphenazine—ADRA2A—female reproductive system—breast cancer	0.000279	0.0084	CbGeAlD
Fluphenazine—HRH1—adrenal gland—breast cancer	0.000277	0.00835	CbGeAlD
Fluphenazine—CYP2E1—female reproductive system—breast cancer	0.000272	0.00822	CbGeAlD
Fluphenazine—ADRA2A—adrenal gland—breast cancer	0.000272	0.0082	CbGeAlD
Fluphenazine—CYP2E1—adrenal gland—breast cancer	0.000266	0.00802	CbGeAlD
Fluphenazine—HTR2A—pituitary gland—breast cancer	0.000259	0.00781	CbGeAlD
Fluphenazine—HRH1—female gonad—breast cancer	0.000258	0.00779	CbGeAlD
Fluphenazine—CYP1A2—endocrine gland—breast cancer	0.000256	0.00774	CbGeAlD
Fluphenazine—ABCB1—embryo—breast cancer	0.000256	0.00773	CbGeAlD
Fluphenazine—ADRA2A—female gonad—breast cancer	0.000253	0.00765	CbGeAlD
Fluphenazine—HRH1—endocrine gland—breast cancer	0.00024	0.00724	CbGeAlD
Fluphenazine—HTR2A—female reproductive system—breast cancer	0.000237	0.00715	CbGeAlD
Fluphenazine—ADRA2A—endocrine gland—breast cancer	0.000236	0.00711	CbGeAlD
Fluphenazine—HTR2A—adrenal gland—breast cancer	0.000231	0.00697	CbGeAlD
Fluphenazine—CYP2E1—endocrine gland—breast cancer	0.000231	0.00696	CbGeAlD
Fluphenazine—CALM2—lymph node—breast cancer	0.000228	0.00689	CbGeAlD
Fluphenazine—CALM1—lymph node—breast cancer	0.000227	0.00686	CbGeAlD
Fluphenazine—CYP2D6—female reproductive system—breast cancer	0.000216	0.00651	CbGeAlD
Fluphenazine—ABCB1—epithelium—breast cancer	0.000209	0.0063	CbGeAlD
Fluphenazine—HTR2A—endocrine gland—breast cancer	0.0002	0.00605	CbGeAlD
Fluphenazine—CYP2D6—female gonad—breast cancer	0.000196	0.00592	CbGeAlD
Fluphenazine—ABCB1—endometrium—breast cancer	0.000187	0.00565	CbGeAlD
Fluphenazine—CYP2D6—endocrine gland—breast cancer	0.000183	0.00551	CbGeAlD
Fluphenazine—ABCB1—uterus—breast cancer	0.000173	0.00521	CbGeAlD
Fluphenazine—ABCB1—pituitary gland—breast cancer	0.00017	0.00512	CbGeAlD
Fluphenazine—ABCB1—adipose tissue—breast cancer	0.000169	0.0051	CbGeAlD
Fluphenazine—HRH1—lymph node—breast cancer	0.000166	0.00501	CbGeAlD
Fluphenazine—ADRA2A—lymph node—breast cancer	0.000163	0.00492	CbGeAlD
Fluphenazine—Triflupromazine—BCHE—breast cancer	0.000159	0.0498	CrCbGaD
Fluphenazine—ABCB1—female reproductive system—breast cancer	0.000155	0.00468	CbGeAlD
Fluphenazine—ABCB1—adrenal gland—breast cancer	0.000151	0.00457	CbGeAlD
Fluphenazine—ABCB1—bone marrow—breast cancer	0.000147	0.00442	CbGeAlD
Fluphenazine—ABCB1—female gonad—breast cancer	0.000141	0.00426	CbGeAlD
Fluphenazine—Urticaria—Goserelin—breast cancer	0.000137	0.000948	CcSEcCtD
Fluphenazine—Hypersensitivity—Vinblastine—breast cancer	0.000136	0.000947	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Methotrexate—breast cancer	0.000136	0.000947	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Capecitabine—breast cancer	0.000136	0.000947	CcSEcCtD
Fluphenazine—Body temperature increased—Goserelin—breast cancer	0.000136	0.000943	CcSEcCtD
Fluphenazine—Leukopenia—Gemcitabine—breast cancer	0.000136	0.000941	CcSEcCtD
Fluphenazine—Hypertension—Irinotecan—breast cancer	0.000134	0.000932	CcSEcCtD
Fluphenazine—Hypertension—Mitoxantrone—breast cancer	0.000134	0.000932	CcSEcCtD
Fluphenazine—Eczema—Epirubicin—breast cancer	0.000134	0.00093	CcSEcCtD
Fluphenazine—Pneumonia—Capecitabine—breast cancer	0.000134	0.00093	CcSEcCtD
Fluphenazine—Decreased appetite—Vinorelbine—breast cancer	0.000134	0.000929	CcSEcCtD
Fluphenazine—Leukopenia—Fluorouracil—breast cancer	0.000133	0.000926	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Methotrexate—breast cancer	0.000133	0.000923	CcSEcCtD
Fluphenazine—Hypersensitivity—Tamoxifen—breast cancer	0.000133	0.00092	CcSEcCtD
Fluphenazine—Constipation—Vinorelbine—breast cancer	0.000132	0.000914	CcSEcCtD
Fluphenazine—Lethargy—Methotrexate—breast cancer	0.000131	0.000911	CcSEcCtD
Fluphenazine—ABCB1—endocrine gland—breast cancer	0.000131	0.00396	CbGeAlD
Fluphenazine—Hypertension—Gemcitabine—breast cancer	0.000131	0.000908	CcSEcCtD
Fluphenazine—Somnolence—Thiotepa—breast cancer	0.000131	0.000907	CcSEcCtD
Fluphenazine—Renal failure acute—Epirubicin—breast cancer	0.00013	0.000905	CcSEcCtD
Fluphenazine—Hypersensitivity—Melphalan—breast cancer	0.00013	0.000901	CcSEcCtD
Fluphenazine—Agranulocytosis—Docetaxel—breast cancer	0.000128	0.000891	CcSEcCtD
Fluphenazine—Decreased appetite—Thiotepa—breast cancer	0.000128	0.000887	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Epirubicin—breast cancer	0.000128	0.000886	CcSEcCtD
Fluphenazine—Pruritus—Tamoxifen—breast cancer	0.000127	0.000884	CcSEcCtD
Fluphenazine—Anaphylactic shock—Mitoxantrone—breast cancer	0.000127	0.000881	CcSEcCtD
Fluphenazine—Anaphylactic shock—Irinotecan—breast cancer	0.000127	0.000881	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—breast cancer	0.000127	0.000881	CcSEcCtD
Fluphenazine—Erythema—Paclitaxel—breast cancer	0.000127	0.00088	CcSEcCtD
Fluphenazine—Hypersensitivity—Goserelin—breast cancer	0.000127	0.000879	CcSEcCtD
Fluphenazine—Constipation—Thiotepa—breast cancer	0.000126	0.000872	CcSEcCtD
Fluphenazine—Pruritus—Melphalan—breast cancer	0.000125	0.000865	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Epirubicin—breast cancer	0.000124	0.000864	CcSEcCtD
Fluphenazine—Agranulocytosis—Capecitabine—breast cancer	0.000124	0.000863	CcSEcCtD
Fluphenazine—Eczema—Doxorubicin—breast cancer	0.000124	0.000861	CcSEcCtD
Fluphenazine—Tachycardia—Mitoxantrone—breast cancer	0.000124	0.00086	CcSEcCtD
Fluphenazine—Anaphylactic shock—Gemcitabine—breast cancer	0.000124	0.000858	CcSEcCtD
Fluphenazine—Skin disorder—Mitoxantrone—breast cancer	0.000123	0.000856	CcSEcCtD
Fluphenazine—Lethargy—Epirubicin—breast cancer	0.000123	0.000853	CcSEcCtD
Fluphenazine—Urticaria—Vinorelbine—breast cancer	0.000122	0.000849	CcSEcCtD
Fluphenazine—Muscle spasms—Paclitaxel—breast cancer	0.000122	0.000847	CcSEcCtD
Fluphenazine—Body temperature increased—Vinorelbine—breast cancer	0.000122	0.000845	CcSEcCtD
Fluphenazine—Oedema peripheral—Docetaxel—breast cancer	0.000122	0.000845	CcSEcCtD
Fluphenazine—Pruritus—Goserelin—breast cancer	0.000122	0.000844	CcSEcCtD
Fluphenazine—Anaphylactic shock—Fluorouracil—breast cancer	0.000122	0.000844	CcSEcCtD
Fluphenazine—Renal failure acute—Doxorubicin—breast cancer	0.000121	0.000838	CcSEcCtD
Fluphenazine—Skin disorder—Gemcitabine—breast cancer	0.00012	0.000834	CcSEcCtD
Fluphenazine—Nausea—Chlorambucil—breast cancer	0.00012	0.000833	CcSEcCtD
Fluphenazine—Vision blurred—Paclitaxel—breast cancer	0.00012	0.00083	CcSEcCtD
Fluphenazine—Tachycardia—Fluorouracil—breast cancer	0.000119	0.000824	CcSEcCtD
Fluphenazine—Hypotension—Irinotecan—breast cancer	0.000119	0.000823	CcSEcCtD
Fluphenazine—Hypotension—Mitoxantrone—breast cancer	0.000119	0.000823	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—breast cancer	0.000118	0.00082	CcSEcCtD
Fluphenazine—Oedema peripheral—Capecitabine—breast cancer	0.000118	0.000818	CcSEcCtD
Fluphenazine—Urticaria—Thiotepa—breast cancer	0.000117	0.000811	CcSEcCtD
Fluphenazine—Agitation—Paclitaxel—breast cancer	0.000117	0.000809	CcSEcCtD
Fluphenazine—Body temperature increased—Thiotepa—breast cancer	0.000116	0.000807	CcSEcCtD
Fluphenazine—Headache—Vinblastine—breast cancer	0.000116	0.000805	CcSEcCtD
Fluphenazine—Angioedema—Paclitaxel—breast cancer	0.000116	0.000805	CcSEcCtD
Fluphenazine—Hypotension—Gemcitabine—breast cancer	0.000116	0.000802	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—breast cancer	0.000115	0.000799	CcSEcCtD
Fluphenazine—Cardiac arrest—Epirubicin—breast cancer	0.000115	0.000795	CcSEcCtD
Fluphenazine—Flupentixol—ABCB1—breast cancer	0.000114	0.0358	CrCbGaD
Fluphenazine—Lethargy—Doxorubicin—breast cancer	0.000114	0.000789	CcSEcCtD
Fluphenazine—Hypotension—Fluorouracil—breast cancer	0.000114	0.000789	CcSEcCtD
Fluphenazine—Leukopenia—Paclitaxel—breast cancer	0.000114	0.000788	CcSEcCtD
Fluphenazine—Hypersensitivity—Vinorelbine—breast cancer	0.000113	0.000787	CcSEcCtD
Fluphenazine—Dyspnoea—Mitoxantrone—breast cancer	0.000113	0.000786	CcSEcCtD
Fluphenazine—Dyspnoea—Irinotecan—breast cancer	0.000113	0.000786	CcSEcCtD
Fluphenazine—Somnolence—Mitoxantrone—breast cancer	0.000113	0.000783	CcSEcCtD
Fluphenazine—Somnolence—Irinotecan—breast cancer	0.000113	0.000783	CcSEcCtD
Fluphenazine—Headache—Tamoxifen—breast cancer	0.000113	0.000782	CcSEcCtD
Fluphenazine—Asthma—Methotrexate—breast cancer	0.000111	0.000772	CcSEcCtD
Fluphenazine—Decreased appetite—Irinotecan—breast cancer	0.00011	0.000766	CcSEcCtD
Fluphenazine—Decreased appetite—Mitoxantrone—breast cancer	0.00011	0.000766	CcSEcCtD
Fluphenazine—Dyspnoea—Gemcitabine—breast cancer	0.00011	0.000765	CcSEcCtD
Fluphenazine—Eosinophilia—Methotrexate—breast cancer	0.00011	0.000764	CcSEcCtD
Fluphenazine—Nausea—Vinblastine—breast cancer	0.00011	0.000764	CcSEcCtD
Fluphenazine—Somnolence—Gemcitabine—breast cancer	0.00011	0.000763	CcSEcCtD
Fluphenazine—Hypertension—Paclitaxel—breast cancer	0.00011	0.00076	CcSEcCtD
Fluphenazine—Mequitazine—CYP2D6—breast cancer	0.000109	0.0342	CrCbGaD
Fluphenazine—Pruritus—Vinorelbine—breast cancer	0.000109	0.000756	CcSEcCtD
Fluphenazine—Constipation—Irinotecan—breast cancer	0.000109	0.000753	CcSEcCtD
Fluphenazine—Constipation—Mitoxantrone—breast cancer	0.000109	0.000753	CcSEcCtD
Fluphenazine—Dyspnoea—Fluorouracil—breast cancer	0.000108	0.000752	CcSEcCtD
Fluphenazine—Hypersensitivity—Thiotepa—breast cancer	0.000108	0.000752	CcSEcCtD
Fluphenazine—Somnolence—Fluorouracil—breast cancer	0.000108	0.00075	CcSEcCtD
Fluphenazine—Headache—Goserelin—breast cancer	0.000108	0.000747	CcSEcCtD
Fluphenazine—Erythema—Docetaxel—breast cancer	0.000108	0.000746	CcSEcCtD
Fluphenazine—Decreased appetite—Gemcitabine—breast cancer	0.000108	0.000746	CcSEcCtD
Fluphenazine—Nausea—Tamoxifen—breast cancer	0.000107	0.000742	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—breast cancer	0.000106	0.000735	CcSEcCtD
Fluphenazine—Constipation—Gemcitabine—breast cancer	0.000106	0.000734	CcSEcCtD
Fluphenazine—Decreased appetite—Fluorouracil—breast cancer	0.000106	0.000734	CcSEcCtD
Fluphenazine—Pancytopenia—Methotrexate—breast cancer	0.000106	0.000733	CcSEcCtD
Fluphenazine—Dry mouth—Paclitaxel—breast cancer	0.000106	0.000733	CcSEcCtD
Fluphenazine—Nausea—Melphalan—breast cancer	0.000105	0.000726	CcSEcCtD
Fluphenazine—Erythema—Capecitabine—breast cancer	0.000104	0.000723	CcSEcCtD
Fluphenazine—Asthma—Epirubicin—breast cancer	0.000104	0.000722	CcSEcCtD
Fluphenazine—Dysphagia—Epirubicin—breast cancer	0.000104	0.000722	CcSEcCtD
Fluphenazine—Pruritus—Thiotepa—breast cancer	0.000104	0.000722	CcSEcCtD
Fluphenazine—Anaphylactic shock—Paclitaxel—breast cancer	0.000104	0.000719	CcSEcCtD
Fluphenazine—Muscle spasms—Docetaxel—breast cancer	0.000103	0.000718	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Methotrexate—breast cancer	0.000103	0.000717	CcSEcCtD
Fluphenazine—Eosinophilia—Epirubicin—breast cancer	0.000103	0.000715	CcSEcCtD
Fluphenazine—Nausea—Goserelin—breast cancer	0.000102	0.000709	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Methotrexate—breast cancer	0.000102	0.000705	CcSEcCtD
Fluphenazine—Tachycardia—Paclitaxel—breast cancer	0.000101	0.000701	CcSEcCtD
Fluphenazine—Urticaria—Mitoxantrone—breast cancer	0.000101	0.0007	CcSEcCtD
Fluphenazine—Skin disorder—Paclitaxel—breast cancer	0.000101	0.000698	CcSEcCtD
Fluphenazine—Body temperature increased—Mitoxantrone—breast cancer	0.0001	0.000697	CcSEcCtD
Fluphenazine—Body temperature increased—Irinotecan—breast cancer	0.0001	0.000697	CcSEcCtD
Fluphenazine—Muscle spasms—Capecitabine—breast cancer	0.0001	0.000695	CcSEcCtD
Fluphenazine—Pneumonia—Methotrexate—breast cancer	9.98e-05	0.000692	CcSEcCtD
Fluphenazine—Drowsiness—Methotrexate—breast cancer	9.92e-05	0.000688	CcSEcCtD
Fluphenazine—Pancytopenia—Epirubicin—breast cancer	9.89e-05	0.000686	CcSEcCtD
Fluphenazine—Vision blurred—Capecitabine—breast cancer	9.81e-05	0.000681	CcSEcCtD
Fluphenazine—Body temperature increased—Gemcitabine—breast cancer	9.78e-05	0.000678	CcSEcCtD
Fluphenazine—Hypotension—Paclitaxel—breast cancer	9.68e-05	0.000671	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Epirubicin—breast cancer	9.68e-05	0.000671	CcSEcCtD
Fluphenazine—Urticaria—Fluorouracil—breast cancer	9.66e-05	0.00067	CcSEcCtD
Fluphenazine—Headache—Vinorelbine—breast cancer	9.64e-05	0.000669	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—breast cancer	9.63e-05	0.000668	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—breast cancer	9.63e-05	0.000668	CcSEcCtD
Fluphenazine—Leukopenia—Docetaxel—breast cancer	9.63e-05	0.000668	CcSEcCtD
Fluphenazine—Body temperature increased—Fluorouracil—breast cancer	9.61e-05	0.000667	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—breast cancer	9.54e-05	0.000662	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Epirubicin—breast cancer	9.5e-05	0.000659	CcSEcCtD
Fluphenazine—Hypersensitivity—Mitoxantrone—breast cancer	9.35e-05	0.000649	CcSEcCtD
Fluphenazine—Hypersensitivity—Irinotecan—breast cancer	9.35e-05	0.000649	CcSEcCtD
Fluphenazine—Mequitazine—CYP3A4—breast cancer	9.34e-05	0.0293	CrCbGaD
Fluphenazine—Pneumonia—Epirubicin—breast cancer	9.34e-05	0.000648	CcSEcCtD
Fluphenazine—Leukopenia—Capecitabine—breast cancer	9.32e-05	0.000647	CcSEcCtD
Fluphenazine—Hypertension—Docetaxel—breast cancer	9.28e-05	0.000644	CcSEcCtD
Fluphenazine—Drowsiness—Epirubicin—breast cancer	9.28e-05	0.000644	CcSEcCtD
Fluphenazine—Agranulocytosis—Methotrexate—breast cancer	9.26e-05	0.000642	CcSEcCtD
Fluphenazine—Dyspnoea—Paclitaxel—breast cancer	9.23e-05	0.000641	CcSEcCtD
Fluphenazine—Headache—Thiotepa—breast cancer	9.21e-05	0.000639	CcSEcCtD
Fluphenazine—Somnolence—Paclitaxel—breast cancer	9.21e-05	0.000639	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—breast cancer	9.15e-05	0.000635	CcSEcCtD
Fluphenazine—Nausea—Vinorelbine—breast cancer	9.14e-05	0.000635	CcSEcCtD
Fluphenazine—ABCB1—lymph node—breast cancer	9.08e-05	0.00274	CbGeAlD
Fluphenazine—Decreased appetite—Paclitaxel—breast cancer	9e-05	0.000625	CcSEcCtD
Fluphenazine—Hypertension—Capecitabine—breast cancer	8.99e-05	0.000624	CcSEcCtD
Fluphenazine—Zuclopenthixol—CYP2D6—breast cancer	8.99e-05	0.0282	CrCbGaD
Fluphenazine—Hypersensitivity—Fluorouracil—breast cancer	8.96e-05	0.000622	CcSEcCtD
Fluphenazine—Dry mouth—Docetaxel—breast cancer	8.95e-05	0.000621	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—breast cancer	8.95e-05	0.000621	CcSEcCtD
Fluphenazine—Nefazodone—CYP2D6—breast cancer	8.94e-05	0.028	CrCbGaD
Fluphenazine—Constipation—Paclitaxel—breast cancer	8.86e-05	0.000614	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—breast cancer	8.79e-05	0.00061	CcSEcCtD
Fluphenazine—Anaphylactic shock—Docetaxel—breast cancer	8.78e-05	0.000609	CcSEcCtD
Fluphenazine—Pruritus—Gemcitabine—breast cancer	8.75e-05	0.000607	CcSEcCtD
Fluphenazine—Nausea—Thiotepa—breast cancer	8.73e-05	0.000606	CcSEcCtD
Fluphenazine—Dry mouth—Capecitabine—breast cancer	8.67e-05	0.000602	CcSEcCtD
Fluphenazine—Agranulocytosis—Epirubicin—breast cancer	8.66e-05	0.000601	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—breast cancer	8.64e-05	0.000599	CcSEcCtD
Fluphenazine—Pruritus—Fluorouracil—breast cancer	8.6e-05	0.000597	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—breast cancer	8.59e-05	0.000596	CcSEcCtD
Fluphenazine—Tachycardia—Docetaxel—breast cancer	8.57e-05	0.000594	CcSEcCtD
Fluphenazine—Skin disorder—Docetaxel—breast cancer	8.53e-05	0.000592	CcSEcCtD
Fluphenazine—Tachycardia—Capecitabine—breast cancer	8.29e-05	0.000576	CcSEcCtD
Fluphenazine—Trazodone—CYP2D6—breast cancer	8.27e-05	0.026	CrCbGaD
Fluphenazine—Skin disorder—Capecitabine—breast cancer	8.25e-05	0.000573	CcSEcCtD
Fluphenazine—Urticaria—Paclitaxel—breast cancer	8.23e-05	0.000571	CcSEcCtD
Fluphenazine—Oedema peripheral—Epirubicin—breast cancer	8.21e-05	0.00057	CcSEcCtD
Fluphenazine—Hypotension—Docetaxel—breast cancer	8.2e-05	0.000569	CcSEcCtD
Fluphenazine—Body temperature increased—Paclitaxel—breast cancer	8.19e-05	0.000568	CcSEcCtD
Fluphenazine—Agranulocytosis—Doxorubicin—breast cancer	8.02e-05	0.000556	CcSEcCtD
Fluphenazine—Headache—Mitoxantrone—breast cancer	7.95e-05	0.000552	CcSEcCtD
Fluphenazine—Headache—Irinotecan—breast cancer	7.95e-05	0.000552	CcSEcCtD
Fluphenazine—Hypotension—Capecitabine—breast cancer	7.94e-05	0.000551	CcSEcCtD
Fluphenazine—Dyspnoea—Docetaxel—breast cancer	7.83e-05	0.000543	CcSEcCtD
Fluphenazine—Somnolence—Docetaxel—breast cancer	7.8e-05	0.000541	CcSEcCtD
Fluphenazine—Erythema—Methotrexate—breast cancer	7.75e-05	0.000538	CcSEcCtD
Fluphenazine—Headache—Gemcitabine—breast cancer	7.75e-05	0.000538	CcSEcCtD
Fluphenazine—Thiothixene—CYP2D6—breast cancer	7.75e-05	0.0243	CrCbGaD
Fluphenazine—Pipotiazine—CYP2D6—breast cancer	7.75e-05	0.0243	CrCbGaD
Fluphenazine—Nefazodone—CYP3A4—breast cancer	7.67e-05	0.0241	CrCbGaD
Fluphenazine—Chlorpromazine—BCHE—breast cancer	7.66e-05	0.024	CrCbGaD
Fluphenazine—Mesoridazine—CYP2D6—breast cancer	7.65e-05	0.024	CrCbGaD
Fluphenazine—Decreased appetite—Docetaxel—breast cancer	7.63e-05	0.000529	CcSEcCtD
Fluphenazine—Hypersensitivity—Paclitaxel—breast cancer	7.63e-05	0.000529	CcSEcCtD
Fluphenazine—Headache—Fluorouracil—breast cancer	7.62e-05	0.000529	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—breast cancer	7.6e-05	0.000527	CcSEcCtD
Fluphenazine—Dyspnoea—Capecitabine—breast cancer	7.58e-05	0.000526	CcSEcCtD
Fluphenazine—Nausea—Mitoxantrone—breast cancer	7.54e-05	0.000523	CcSEcCtD
Fluphenazine—Nausea—Irinotecan—breast cancer	7.54e-05	0.000523	CcSEcCtD
Fluphenazine—Constipation—Docetaxel—breast cancer	7.51e-05	0.000521	CcSEcCtD
Fluphenazine—Prochlorperazine—CYP2D6—breast cancer	7.4e-05	0.0232	CrCbGaD
Fluphenazine—Decreased appetite—Capecitabine—breast cancer	7.39e-05	0.000513	CcSEcCtD
Fluphenazine—Nausea—Gemcitabine—breast cancer	7.35e-05	0.00051	CcSEcCtD
Fluphenazine—Pruritus—Paclitaxel—breast cancer	7.33e-05	0.000508	CcSEcCtD
Fluphenazine—Vision blurred—Methotrexate—breast cancer	7.3e-05	0.000507	CcSEcCtD
Fluphenazine—Constipation—Capecitabine—breast cancer	7.27e-05	0.000504	CcSEcCtD
Fluphenazine—Erythema—Epirubicin—breast cancer	7.25e-05	0.000503	CcSEcCtD
Fluphenazine—Nausea—Fluorouracil—breast cancer	7.22e-05	0.000501	CcSEcCtD
Fluphenazine—Trazodone—CYP3A4—breast cancer	7.09e-05	0.0223	CrCbGaD
Fluphenazine—Muscle spasms—Epirubicin—breast cancer	6.97e-05	0.000484	CcSEcCtD
Fluphenazine—Body temperature increased—Docetaxel—breast cancer	6.94e-05	0.000481	CcSEcCtD
Fluphenazine—Leukopenia—Methotrexate—breast cancer	6.94e-05	0.000481	CcSEcCtD
Fluphenazine—Vision blurred—Epirubicin—breast cancer	6.84e-05	0.000474	CcSEcCtD
Fluphenazine—Urticaria—Capecitabine—breast cancer	6.75e-05	0.000468	CcSEcCtD
Fluphenazine—Body temperature increased—Capecitabine—breast cancer	6.72e-05	0.000466	CcSEcCtD
Fluphenazine—Erythema—Doxorubicin—breast cancer	6.71e-05	0.000466	CcSEcCtD
Fluphenazine—Agitation—Epirubicin—breast cancer	6.67e-05	0.000463	CcSEcCtD
Fluphenazine—Pipotiazine—CYP3A4—breast cancer	6.65e-05	0.0209	CrCbGaD
Fluphenazine—Leukopenia—Epirubicin—breast cancer	6.49e-05	0.000451	CcSEcCtD
Fluphenazine—Headache—Paclitaxel—breast cancer	6.49e-05	0.00045	CcSEcCtD
Fluphenazine—Hypersensitivity—Docetaxel—breast cancer	6.47e-05	0.000449	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—breast cancer	6.45e-05	0.000448	CcSEcCtD
Fluphenazine—Nefazodone—ABCB1—breast cancer	6.38e-05	0.02	CrCbGaD
Fluphenazine—Prochlorperazine—CYP3A4—breast cancer	6.35e-05	0.0199	CrCbGaD
Fluphenazine—Anaphylactic shock—Methotrexate—breast cancer	6.33e-05	0.000439	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—breast cancer	6.33e-05	0.000439	CcSEcCtD
Fluphenazine—Hypertension—Epirubicin—breast cancer	6.26e-05	0.000435	CcSEcCtD
Fluphenazine—Hypersensitivity—Capecitabine—breast cancer	6.26e-05	0.000434	CcSEcCtD
Fluphenazine—Triflupromazine—ABCB1—breast cancer	6.22e-05	0.0195	CrCbGaD
Fluphenazine—Pruritus—Docetaxel—breast cancer	6.21e-05	0.000431	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—breast cancer	6.17e-05	0.000428	CcSEcCtD
Fluphenazine—Nausea—Paclitaxel—breast cancer	6.15e-05	0.000427	CcSEcCtD
Fluphenazine—Skin disorder—Methotrexate—breast cancer	6.14e-05	0.000426	CcSEcCtD
Fluphenazine—Dry mouth—Epirubicin—breast cancer	6.04e-05	0.000419	CcSEcCtD
Fluphenazine—Acepromazine—ALB—breast cancer	6.03e-05	0.0189	CrCbGaD
Fluphenazine—Pruritus—Capecitabine—breast cancer	6.01e-05	0.000417	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—breast cancer	6.01e-05	0.000417	CcSEcCtD
Fluphenazine—Anaphylactic shock—Epirubicin—breast cancer	5.92e-05	0.000411	CcSEcCtD
Fluphenazine—Hypotension—Methotrexate—breast cancer	5.91e-05	0.00041	CcSEcCtD
Fluphenazine—Trazodone—ABCB1—breast cancer	5.9e-05	0.0185	CrCbGaD
Fluphenazine—Thioproperazine—ALB—breast cancer	5.89e-05	0.0185	CrCbGaD
Fluphenazine—Pipotiazine—ALB—breast cancer	5.8e-05	0.0182	CrCbGaD
Fluphenazine—Thiothixene—ALB—breast cancer	5.8e-05	0.0182	CrCbGaD
Fluphenazine—Hypertension—Doxorubicin—breast cancer	5.79e-05	0.000402	CcSEcCtD
Fluphenazine—Tachycardia—Epirubicin—breast cancer	5.78e-05	0.000401	CcSEcCtD
Fluphenazine—Thioridazine—CYP2D6—breast cancer	5.77e-05	0.0181	CrCbGaD
Fluphenazine—Skin disorder—Epirubicin—breast cancer	5.75e-05	0.000399	CcSEcCtD
Fluphenazine—Dyspnoea—Methotrexate—breast cancer	5.64e-05	0.000391	CcSEcCtD
Fluphenazine—Somnolence—Methotrexate—breast cancer	5.62e-05	0.00039	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—breast cancer	5.59e-05	0.000388	CcSEcCtD
Fluphenazine—Hypotension—Epirubicin—breast cancer	5.53e-05	0.000384	CcSEcCtD
Fluphenazine—Methotrimeprazine—CYP2D6—breast cancer	5.51e-05	0.0173	CrCbGaD
Fluphenazine—Decreased appetite—Methotrexate—breast cancer	5.5e-05	0.000382	CcSEcCtD
Fluphenazine—Headache—Docetaxel—breast cancer	5.5e-05	0.000382	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—breast cancer	5.48e-05	0.00038	CcSEcCtD
Fluphenazine—Tachycardia—Doxorubicin—breast cancer	5.35e-05	0.000371	CcSEcCtD
Fluphenazine—Headache—Capecitabine—breast cancer	5.32e-05	0.000369	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—breast cancer	5.32e-05	0.000369	CcSEcCtD
Fluphenazine—Perphenazine—CYP2D6—breast cancer	5.3e-05	0.0166	CrCbGaD
Fluphenazine—Dyspnoea—Epirubicin—breast cancer	5.28e-05	0.000366	CcSEcCtD
Fluphenazine—Somnolence—Epirubicin—breast cancer	5.26e-05	0.000365	CcSEcCtD
Fluphenazine—Nausea—Docetaxel—breast cancer	5.21e-05	0.000362	CcSEcCtD
Fluphenazine—Quetiapine—CYP2D6—breast cancer	5.19e-05	0.0163	CrCbGaD
Fluphenazine—Decreased appetite—Epirubicin—breast cancer	5.15e-05	0.000357	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—breast cancer	5.12e-05	0.000355	CcSEcCtD
Fluphenazine—Constipation—Epirubicin—breast cancer	5.06e-05	0.000351	CcSEcCtD
Fluphenazine—Nausea—Capecitabine—breast cancer	5.05e-05	0.00035	CcSEcCtD
Fluphenazine—Urticaria—Methotrexate—breast cancer	5.03e-05	0.000349	CcSEcCtD
Fluphenazine—Body temperature increased—Methotrexate—breast cancer	5e-05	0.000347	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—breast cancer	4.88e-05	0.000339	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—breast cancer	4.87e-05	0.000338	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—breast cancer	4.76e-05	0.00033	CcSEcCtD
Fluphenazine—Urticaria—Epirubicin—breast cancer	4.7e-05	0.000326	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—breast cancer	4.68e-05	0.000325	CcSEcCtD
Fluphenazine—Body temperature increased—Epirubicin—breast cancer	4.68e-05	0.000325	CcSEcCtD
Fluphenazine—Hypersensitivity—Methotrexate—breast cancer	4.66e-05	0.000323	CcSEcCtD
Fluphenazine—Perphenazine—CYP3A4—breast cancer	4.54e-05	0.0143	CrCbGaD
Fluphenazine—Pruritus—Methotrexate—breast cancer	4.48e-05	0.000311	CcSEcCtD
Fluphenazine—Quetiapine—CYP3A4—breast cancer	4.45e-05	0.014	CrCbGaD
Fluphenazine—Hypersensitivity—Epirubicin—breast cancer	4.36e-05	0.000303	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—breast cancer	4.35e-05	0.000302	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—breast cancer	4.33e-05	0.0003	CcSEcCtD
Fluphenazine—Chlorpromazine—CYP2D6—breast cancer	4.2e-05	0.0132	CrCbGaD
Fluphenazine—Pruritus—Epirubicin—breast cancer	4.19e-05	0.000291	CcSEcCtD
Fluphenazine—Promazine—CYP3A4—breast cancer	4.09e-05	0.0129	CrCbGaD
Fluphenazine—Hypersensitivity—Doxorubicin—breast cancer	4.04e-05	0.00028	CcSEcCtD
Fluphenazine—Headache—Methotrexate—breast cancer	3.96e-05	0.000275	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—breast cancer	3.88e-05	0.000269	CcSEcCtD
Fluphenazine—Trifluoperazine—ABCB1—breast cancer	3.82e-05	0.012	CrCbGaD
Fluphenazine—Nausea—Methotrexate—breast cancer	3.76e-05	0.000261	CcSEcCtD
Fluphenazine—Headache—Epirubicin—breast cancer	3.71e-05	0.000257	CcSEcCtD
Fluphenazine—Quetiapine—ABCB1—breast cancer	3.71e-05	0.0116	CrCbGaD
Fluphenazine—Chlorpromazine—CYP3A4—breast cancer	3.6e-05	0.0113	CrCbGaD
Fluphenazine—Nausea—Epirubicin—breast cancer	3.52e-05	0.000244	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—breast cancer	3.43e-05	0.000238	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—breast cancer	3.25e-05	0.000226	CcSEcCtD
Fluphenazine—Chlorpromazine—ALB—breast cancer	3.14e-05	0.00987	CrCbGaD
Fluphenazine—Chlorpromazine—ABCB1—breast cancer	3e-05	0.00941	CrCbGaD
Fluphenazine—CALM1—Signaling by GPCR—PIK3CA—breast cancer	1.46e-06	9.5e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—breast cancer	1.46e-06	9.48e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MDM2—breast cancer	1.46e-06	9.46e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MDM2—breast cancer	1.46e-06	9.46e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.46e-06	9.45e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—breast cancer	1.45e-06	9.44e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—breast cancer	1.45e-06	9.44e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—breast cancer	1.45e-06	9.44e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—breast cancer	1.45e-06	9.44e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—RAF1—breast cancer	1.45e-06	9.42e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—RAF1—breast cancer	1.45e-06	9.42e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.45e-06	9.42e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFB1—breast cancer	1.45e-06	9.41e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFB1—breast cancer	1.45e-06	9.41e-06	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PIK3CA—breast cancer	1.45e-06	9.4e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—RELA—breast cancer	1.45e-06	9.38e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—RELA—breast cancer	1.45e-06	9.38e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—NOS3—breast cancer	1.44e-06	9.34e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.44e-06	9.33e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—SRC—breast cancer	1.44e-06	9.33e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ERBB2—breast cancer	1.44e-06	9.32e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ERBB2—breast cancer	1.44e-06	9.32e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.44e-06	9.32e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EGFR—breast cancer	1.43e-06	9.32e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—JUN—breast cancer	1.43e-06	9.31e-06	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PIK3CA—breast cancer	1.43e-06	9.28e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EGFR—breast cancer	1.43e-06	9.27e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.42e-06	9.24e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EGFR—breast cancer	1.42e-06	9.23e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EGFR—breast cancer	1.42e-06	9.23e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CB—breast cancer	1.42e-06	9.2e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CB—breast cancer	1.42e-06	9.2e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MTOR—breast cancer	1.42e-06	9.2e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MTOR—breast cancer	1.42e-06	9.2e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ALB—breast cancer	1.42e-06	9.2e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SRC—breast cancer	1.41e-06	9.18e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SRC—breast cancer	1.41e-06	9.16e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCL8—breast cancer	1.41e-06	9.14e-06	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—breast cancer	1.4e-06	9.1e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—breast cancer	1.4e-06	9.09e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—breast cancer	1.4e-06	9.08e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.4e-06	9.06e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.39e-06	9.03e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—breast cancer	1.39e-06	9.01e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.39e-06	9.01e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STAT3—breast cancer	1.39e-06	9e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CG—breast cancer	1.38e-06	8.98e-06	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—breast cancer	1.38e-06	8.98e-06	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PIK3CA—breast cancer	1.38e-06	8.97e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.38e-06	8.94e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1B—breast cancer	1.37e-06	8.93e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—breast cancer	1.37e-06	8.92e-06	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—breast cancer	1.37e-06	8.92e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STAT3—breast cancer	1.36e-06	8.86e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCL8—breast cancer	1.36e-06	8.84e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCL8—breast cancer	1.36e-06	8.84e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STAT3—breast cancer	1.36e-06	8.84e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.36e-06	8.81e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—NOS3—breast cancer	1.36e-06	8.8e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—breast cancer	1.36e-06	8.8e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.35e-06	8.79e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—breast cancer	1.35e-06	8.78e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—breast cancer	1.35e-06	8.78e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—breast cancer	1.35e-06	8.76e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP3—breast cancer	1.35e-06	8.75e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL2—breast cancer	1.35e-06	8.74e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—breast cancer	1.34e-06	8.72e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—breast cancer	1.34e-06	8.72e-06	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—breast cancer	1.34e-06	8.7e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—breast cancer	1.34e-06	8.69e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PIK3CA—breast cancer	1.34e-06	8.68e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PIK3CA—breast cancer	1.34e-06	8.68e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1B—breast cancer	1.33e-06	8.64e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1B—breast cancer	1.33e-06	8.64e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CB—breast cancer	1.33e-06	8.62e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK3—breast cancer	1.32e-06	8.6e-06	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—breast cancer	1.32e-06	8.58e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—breast cancer	1.32e-06	8.54e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCND1—breast cancer	1.31e-06	8.52e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—JUN—breast cancer	1.31e-06	8.5e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP3—breast cancer	1.3e-06	8.46e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP3—breast cancer	1.3e-06	8.46e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.3e-06	8.46e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL2—breast cancer	1.3e-06	8.45e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL2—breast cancer	1.3e-06	8.45e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK3—breast cancer	1.3e-06	8.44e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CTNNB1—breast cancer	1.3e-06	8.43e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—breast cancer	1.29e-06	8.41e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—breast cancer	1.29e-06	8.41e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—breast cancer	1.29e-06	8.36e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SRC—breast cancer	1.29e-06	8.35e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFB1—breast cancer	1.28e-06	8.34e-06	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—breast cancer	1.28e-06	8.33e-06	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—breast cancer	1.28e-06	8.3e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PIK3CA—breast cancer	1.28e-06	8.28e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—breast cancer	1.27e-06	8.27e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1A—breast cancer	1.27e-06	8.24e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCND1—breast cancer	1.27e-06	8.24e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCND1—breast cancer	1.27e-06	8.24e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—breast cancer	1.27e-06	8.23e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—JUN—breast cancer	1.27e-06	8.22e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—JUN—breast cancer	1.27e-06	8.22e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTEN—breast cancer	1.27e-06	8.22e-06	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—breast cancer	1.27e-06	8.22e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—breast cancer	1.26e-06	8.21e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.26e-06	8.21e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFB1—breast cancer	1.26e-06	8.19e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EGFR—breast cancer	1.26e-06	8.18e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CTNNB1—breast cancer	1.26e-06	8.16e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CTNNB1—breast cancer	1.26e-06	8.16e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.25e-06	8.14e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.25e-06	8.12e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.25e-06	8.09e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.24e-06	8.06e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—breast cancer	1.24e-06	8.05e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EGFR—breast cancer	1.24e-06	8.05e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.24e-06	8.04e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK8—breast cancer	1.24e-06	8.04e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EGFR—breast cancer	1.24e-06	8.03e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—breast cancer	1.24e-06	8.03e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—breast cancer	1.24e-06	8.03e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—breast cancer	1.23e-06	8.02e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PIK3CA—breast cancer	1.23e-06	8.01e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PIK3CA—breast cancer	1.23e-06	8.01e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—breast cancer	1.23e-06	8e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—breast cancer	1.23e-06	8e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1A—breast cancer	1.23e-06	7.97e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1A—breast cancer	1.23e-06	7.97e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTEN—breast cancer	1.22e-06	7.95e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTEN—breast cancer	1.22e-06	7.95e-06	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—breast cancer	1.22e-06	7.94e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.22e-06	7.9e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—breast cancer	1.2e-06	7.82e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ALB—breast cancer	1.2e-06	7.79e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—breast cancer	1.2e-06	7.78e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK8—breast cancer	1.2e-06	7.78e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK8—breast cancer	1.2e-06	7.78e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—breast cancer	1.19e-06	7.76e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—breast cancer	1.19e-06	7.76e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—breast cancer	1.19e-06	7.73e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.19e-06	7.7e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—breast cancer	1.18e-06	7.68e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—breast cancer	1.18e-06	7.68e-06	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—breast cancer	1.18e-06	7.68e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—breast cancer	1.18e-06	7.66e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SRC—breast cancer	1.17e-06	7.62e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—breast cancer	1.17e-06	7.6e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PIK3CA—breast cancer	1.17e-06	7.6e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—breast cancer	1.17e-06	7.59e-06	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—breast cancer	1.17e-06	7.58e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—breast cancer	1.15e-06	7.49e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—breast cancer	1.15e-06	7.48e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.15e-06	7.47e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—NOS3—breast cancer	1.15e-06	7.46e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTEN—breast cancer	1.15e-06	7.45e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—breast cancer	1.15e-06	7.44e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—breast cancer	1.14e-06	7.42e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—breast cancer	1.14e-06	7.41e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—breast cancer	1.14e-06	7.41e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SRC—breast cancer	1.14e-06	7.37e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SRC—breast cancer	1.14e-06	7.37e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STAT3—breast cancer	1.13e-06	7.35e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—breast cancer	1.13e-06	7.33e-06	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—breast cancer	1.13e-06	7.33e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.13e-06	7.32e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—breast cancer	1.11e-06	7.18e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—breast cancer	1.11e-06	7.18e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—breast cancer	1.1e-06	7.16e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—breast cancer	1.1e-06	7.12e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STAT3—breast cancer	1.1e-06	7.11e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STAT3—breast cancer	1.1e-06	7.11e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.09e-06	7.1e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—breast cancer	1.09e-06	7.09e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—breast cancer	1.09e-06	7.09e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—breast cancer	1.09e-06	7.09e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—breast cancer	1.09e-06	7.09e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK3—breast cancer	1.08e-06	7.02e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTEN—breast cancer	1.08e-06	7.02e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.08e-06	6.99e-06	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PIK3CA—breast cancer	1.07e-06	6.98e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.07e-06	6.97e-06	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PIK3CA—breast cancer	1.07e-06	6.93e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.07e-06	6.92e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CB—breast cancer	1.06e-06	6.88e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—breast cancer	1.06e-06	6.87e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—breast cancer	1.05e-06	6.83e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—breast cancer	1.05e-06	6.82e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFB1—breast cancer	1.05e-06	6.81e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK3—breast cancer	1.05e-06	6.79e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK3—breast cancer	1.05e-06	6.79e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—breast cancer	1.04e-06	6.76e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—breast cancer	1.04e-06	6.76e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—breast cancer	1.04e-06	6.74e-06	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PIK3CA—breast cancer	1.03e-06	6.71e-06	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PIK3CA—breast cancer	1.03e-06	6.71e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EGFR—breast cancer	1.03e-06	6.68e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—breast cancer	1.02e-06	6.61e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—breast cancer	1.02e-06	6.61e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—breast cancer	1.02e-06	6.61e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFB1—breast cancer	1.02e-06	6.59e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFB1—breast cancer	1.02e-06	6.59e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—breast cancer	1.01e-06	6.57e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—breast cancer	1.01e-06	6.57e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—breast cancer	1.01e-06	6.54e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—breast cancer	1.01e-06	6.54e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EGFR—breast cancer	9.95e-07	6.46e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EGFR—breast cancer	9.95e-07	6.46e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—breast cancer	9.95e-07	6.46e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—breast cancer	9.93e-07	6.45e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	9.79e-07	6.36e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—breast cancer	9.72e-07	6.31e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—breast cancer	9.68e-07	6.29e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—breast cancer	9.56e-07	6.21e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—breast cancer	9.53e-07	6.19e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—breast cancer	9.51e-07	6.17e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—breast cancer	9.47e-07	6.15e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—breast cancer	9.4e-07	6.11e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—breast cancer	9.4e-07	6.11e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTEN—breast cancer	9.16e-07	5.95e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—breast cancer	9.06e-07	5.88e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—breast cancer	8.93e-07	5.8e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CA—breast cancer	8.93e-07	5.8e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—breast cancer	8.79e-07	5.71e-06	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—breast cancer	8.78e-07	5.7e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—breast cancer	8.77e-07	5.69e-06	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—breast cancer	8.72e-07	5.67e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—breast cancer	8.67e-07	5.63e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—breast cancer	8.64e-07	5.61e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CA—breast cancer	8.64e-07	5.61e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CA—breast cancer	8.64e-07	5.61e-06	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—breast cancer	8.44e-07	5.48e-06	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—breast cancer	8.44e-07	5.48e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—breast cancer	8.36e-07	5.43e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—breast cancer	8.36e-07	5.43e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—breast cancer	8.26e-07	5.36e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CA—breast cancer	8.09e-07	5.26e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—breast cancer	8e-07	5.19e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—breast cancer	7.99e-07	5.19e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—breast cancer	7.99e-07	5.19e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—breast cancer	7.91e-07	5.13e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—breast cancer	7.65e-07	4.97e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—breast cancer	7.65e-07	4.97e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CA—breast cancer	7.63e-07	4.95e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—breast cancer	7.3e-07	4.74e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—breast cancer	7.06e-07	4.58e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—breast cancer	7.06e-07	4.58e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—breast cancer	6.61e-07	4.29e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CA—breast cancer	6.46e-07	4.2e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—breast cancer	6.23e-07	4.05e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—breast cancer	5.28e-07	3.43e-06	CbGpPWpGaD
